209 filings
Page 2 of 11
UPLOAD
pepw3pdh8i
21 Nov 23
Letter from SEC
12:00am
CORRESP
6mg2bajnpv46 axpp2
21 Nov 23
Correspondence with SEC
12:00am
S-8
f7aizi n91t6
17 Nov 23
Registration of securities for employees
5:01pm
8-K
h02l3729rx
13 Nov 23
Checkpoint Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
5:10pm
8-K
f0cwszuttvlk2f884
3 Oct 23
Checkpoint Therapeutics Announces Exercise of Warrants for $11.13 Million in Gross Proceeds
5:00pm
8-K
wg862n
14 Aug 23
Checkpoint Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
4:30pm
8-K
9me g1rnr
31 Jul 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market
8:28am
424B5
n9lf f3v3
31 Jul 23
Prospectus supplement for primary offering
8:23am
8-K
b9bg17of6uxy9r
27 Jul 23
55% objective response rate; 23% complete response rate in locally advanced cSCC
7:30am
8-K
la2rcjw
13 Jun 23
Departure of Directors or Certain Officers
7:00am
424B5
t1hiznsiw4k7
24 May 23
Prospectus supplement for primary offering
5:25pm
8-K
o43wfp
24 May 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
5:24pm
8-K
1agi6z b2k2
15 May 23
Checkpoint Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
4:21pm
EFFECT
a662afvle3 0f66bfgz
8 May 23
Notice of effectiveness
12:15am
EFFECT
0iwu4h04iphll 927hqs
8 May 23
Notice of effectiveness
12:15am
EFFECT
kpn078k8ig ktvcu4f8
8 May 23
Notice of effectiveness
12:15am